Supplies your cost report can stand behind.

Before you choose

Questions worth settling before you book.

Is this purchasing work or a DME software product?

This page describes a scoped, staffed procurement service. It does not imply that a NEXUS DME product is available or that LUCA replaces the agency's clinical or vendor systems.

Is LUCA approved as a Nebraska Medicaid DME provider?

Yes. LUCA L.L.C. is an approved, active Nebraska Medicaid DME provider, effective September 25, 2026. Provider type: Rental and Retail Supplier (RTLR)(62). Specialty: Medical Supply Company not included in 51, 52 or 53. This confirms provider approval and active participation, not just an enrollment application. It is separate from the availability of NEXUS DME software.

Does provider approval mean every DME item or claim is covered?

No. Coverage, any required authorization, documentation, and payment depend on the item, member, and applicable payer requirements. Provider approval is not a guarantee of coverage or payment, or a claim that LUCA holds every managed-care contract. Discuss the supply need first without patient names, claim numbers, or records; use an approved secure channel for any record-level review.

Who chooses a clinically appropriate supply?

The agency retains clinical choice and its approval authority. A purchasing workflow can track the requested item, permitted substitutions, cost, delivery, and exceptions, but it must not substitute a cheaper item for a clinical decision.

What should we bring to a procurement scope call?

Bring branch count, broad item categories, approximate order volume, delivery methods, vendor arrangements, approval roles, and agency-level spend or exception measures. The first conversation does not require a patient order, address, or identifier.

Should we use branch stock, clinician-carried stock, or direct-to-patient delivery?

That depends on item demand, urgency, storage, geography, delivery reliability, and who will receive and reconcile each order. Compare the full handoff and delivered cost for each category instead of applying one model to every supply.

What happens when an order is short, late, or substituted?

The written scope should identify who notices the exception, who contacts the vendor, who approves a clinically acceptable alternative, and how receipt or return is recorded. A purchasing desk cannot promise a distributor's delivery performance or make the clinical substitution decision.

Are medical supplies and DME accounted for the same way?

No universal rule covers every item and payer. CMS includes routine and nonroutine medical supplies in the home-health PPS consolidated-billing framework, with specified exceptions including DME. Cost-report treatment also depends on the actual cost and charge category. The agency's billing and accounting owners must confirm current rules for the item and payer.

How would we judge whether the purchasing work helps?

Start with an agency-level baseline: order-to-receipt time, short shipments, substitutions, stockouts, returns, and spend by category if available. Agree on a review cadence and who validates the data. These are evaluation measures, not a promised savings or delivery outcome.